Robert Fecik

1.6k total citations
27 papers, 1.3k citations indexed

About

Robert Fecik is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Robert Fecik has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 14 papers in Organic Chemistry and 14 papers in Molecular Biology. Recurrent topics in Robert Fecik's work include Microbial Natural Products and Biosynthesis (18 papers), Carbohydrate Chemistry and Synthesis (10 papers) and Phytochemical compounds biological activities (7 papers). Robert Fecik is often cited by papers focused on Microbial Natural Products and Biosynthesis (18 papers), Carbohydrate Chemistry and Synthesis (10 papers) and Phytochemical compounds biological activities (7 papers). Robert Fecik collaborates with scholars based in United States, China and India. Robert Fecik's co-authors include David H. Sherman, Dale L. Boger, Courtney C. Aldrich, Benjamin F. Cravatt, Hiroshi Miyauchi, Michael P. Hedrick, Janet L. Smith, Matthew P. Patricelli, Lakshmanan Venkatraman and David L. Akey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

Robert Fecik

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Fecik United States 17 938 595 423 196 186 27 1.3k
Christophe Hardouin France 16 626 0.7× 444 0.7× 581 1.4× 233 1.2× 34 0.2× 23 1.4k
Marianna Nalli Italy 21 304 0.3× 375 0.6× 238 0.6× 158 0.8× 13 0.1× 52 1.1k
Matthias Lehr Germany 21 405 0.4× 629 1.1× 328 0.8× 104 0.5× 9 0.0× 99 1.3k
Katerina Otrubova United States 12 250 0.3× 299 0.5× 172 0.4× 38 0.2× 38 0.2× 15 563
Diego Caprioglio Italy 18 379 0.4× 267 0.4× 227 0.5× 86 0.4× 16 0.1× 54 824
Paolo Lazzari Italy 18 385 0.4× 267 0.4× 232 0.5× 228 1.2× 17 0.1× 43 847
Li-Fang Yu China 24 243 0.3× 853 1.4× 430 1.0× 67 0.3× 13 0.1× 63 1.4k
Isao Kaneko Japan 15 285 0.3× 614 1.0× 136 0.3× 115 0.6× 143 0.8× 26 1.2k
Alaa M. Hayallah Egypt 24 126 0.1× 780 1.3× 856 2.0× 152 0.8× 34 0.2× 67 1.7k
C. DUFRESNE United States 8 248 0.3× 284 0.5× 109 0.3× 91 0.5× 57 0.3× 14 616

Countries citing papers authored by Robert Fecik

Since Specialization
Citations

This map shows the geographic impact of Robert Fecik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Fecik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Fecik more than expected).

Fields of papers citing papers by Robert Fecik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Fecik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Fecik. The network helps show where Robert Fecik may publish in the future.

Co-authorship network of co-authors of Robert Fecik

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Fecik. A scholar is included among the top collaborators of Robert Fecik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Fecik. Robert Fecik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterson, Michael, et al.. (2015). Chemistry and biology of tubulysins: antimitotic tetrapeptides with activity against drug resistant cancers. Natural Product Reports. 32(5). 654–662. 60 indexed citations
2.
Li, Yang, William D. Fiers, Steffen M. Bernard, et al.. (2014). Polyketide Intermediate Mimics as Probes for Revealing Cryptic Stereochemistry of Ketoreductase Domains. ACS Chemical Biology. 9(12). 2914–2922. 14 indexed citations
3.
Akey, David L., et al.. (2010). A general scheme for synthesis of substrate-based polyketide labels for acyl carrier proteins. Bioorganic & Medicinal Chemistry Letters. 20(19). 5939–5942. 2 indexed citations
4.
Sackett, Dan L., et al.. (2008). Tubulysin analogs incorporating desmethyl and dimethyl tubuphenylalanine derivatives. Bioorganic & Medicinal Chemistry Letters. 18(9). 2996–2999. 28 indexed citations
5.
Gupta, Shuchi, Lakshmanan Venkatraman, Beom Seok Kim, Robert Fecik, & Kevin A. Reynolds. (2008). Generation of Novel Pikromycin Antibiotic Products Through Mutasynthesis. ChemBioChem. 9(10). 1609–1616. 11 indexed citations
6.
Begaye, Adrian, et al.. (2008). Total Synthesis and Biological Evaluation of Tubulysin U, Tubulysin V, and Their Analogues. Journal of Medicinal Chemistry. 52(2). 238–240. 49 indexed citations
7.
Sackett, Dan L., et al.. (2008). Cytotoxic Simplified Tubulysin Analogues. Journal of Medicinal Chemistry. 51(6). 1530–1533. 52 indexed citations
8.
Giraldes, J., David L. Akey, Jeffrey D. Kittendorf, et al.. (2006). Structural and mechanistic insights into polyketide macrolactonization from polyketide-based affinity labels. Nature Chemical Biology. 2(10). 531–536. 73 indexed citations
9.
Akey, David L., Jeffrey D. Kittendorf, J. Giraldes, et al.. (2006). Structural basis for macrolactonization by the pikromycin thioesterase. Nature Chemical Biology. 2(10). 537–542. 96 indexed citations
10.
Venkatraman, Lakshmanan, Christine Salomon, David H. Sherman, & Robert Fecik. (2006). Total Synthesis of Narbonolide and Biotransformation to Pikromycin. The Journal of Organic Chemistry. 71(26). 9853–9856. 16 indexed citations
11.
Aldrich, Courtney C., Brian J. Beck, Robert Fecik, & David H. Sherman. (2005). Biochemical Investigation of Pikromycin Biosynthesis Employing Native Penta- and Hexaketide Chain Elongation Intermediates. Journal of the American Chemical Society. 127(23). 8441–8452. 46 indexed citations
12.
13.
Venkatraman, Lakshmanan, Courtney C. Aldrich, David H. Sherman, & Robert Fecik. (2005). Formal Total Synthesis of the Polyketide Macrolactone Narbonolide. The Journal of Organic Chemistry. 70(18). 7267–7272. 13 indexed citations
14.
Fecik, Robert, et al.. (2005). Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.. PubMed. 8(6). 741–7. 18 indexed citations
15.
Aldrich, Courtney C., Lakshmanan Venkatraman, David H. Sherman, & Robert Fecik. (2005). Chemoenzymatic Synthesis of the Polyketide Macrolactone 10-Deoxymethynolide. Journal of the American Chemical Society. 127(25). 8910–8911. 54 indexed citations
16.
Boger, Dale L., Hiroshi Miyauchi, Wu Du, et al.. (2004). Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as Analgesics. Journal of Medicinal Chemistry. 48(6). 1849–1856. 187 indexed citations
17.
Boger, Dale L., Robert Fecik, Jean E. Patterson, et al.. (2000). Fatty acid amide hydrolase substrate specificity. Bioorganic & Medicinal Chemistry Letters. 10(23). 2613–2616. 84 indexed citations
18.
Boger, Dale L., Haruhiko Sato, Michael P. Hedrick, et al.. (2000). Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide. Proceedings of the National Academy of Sciences. 97(10). 5044–5049. 238 indexed citations
19.
Fecik, Robert, et al.. (1998). The search for orally active medications through combinatorial chemistry. Medicinal Research Reviews. 18(3). 149–185. 1 indexed citations
20.
Fecik, Robert, et al.. (1998). The search for orally active medications through combinatorial chemistry. Medicinal Research Reviews. 18(3). 149–185. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Hardouin Breakdown of academic impact, for papers by Marianna Nalli Breakdown of academic impact, for papers by Matthias Lehr Breakdown of academic impact, for papers by Katerina Otrubova Breakdown of academic impact, for papers by Diego Caprioglio Breakdown of academic impact, for papers by Paolo Lazzari Breakdown of academic impact, for papers by Li-Fang Yu Breakdown of academic impact, for papers by Isao Kaneko Breakdown of academic impact, for papers by Alaa M. Hayallah Breakdown of academic impact, for papers by C. DUFRESNE
Rankless by CCL
2026